GIBBS MICHAEL TERRENCE (General Counsel) purchased 6.4% of their position (10K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market purchase worth $4.9K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/11/2022ACC: 0000899243-22-014416
Officer· General Counsel
Since Jul 2018
+10K
Net shares
Net buyer
$4.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.49
Trade value
$4.90K
% of position
6.4%
4/7/2022
156.65K→166.65K
Total
Net shares
+10K
Net value
$4.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/7/2022 | P · Purchase | +10K | $0.49 | $4.90K | 6.4% | 156.65K | 166.65K |
| Total | +10K | $4.90K | ||||||
Derivative Transactions0
No derivative transactions reported